🇺🇸 FDA
Pipeline program

CD19 CAR T-cell

BJGBYY-IIT-LCYJ-2023-003

Unknown small_molecule active

Quick answer

CD19 CAR T-cell for B-cell Acute Lymphoblastic Leukemia is a Unknown program (small_molecule) at INTEGRATED BIOPHARMA INC with 1 ClinicalTrials.gov record(s).

Program details

Company
INTEGRATED BIOPHARMA INC
Indication
B-cell Acute Lymphoblastic Leukemia
Phase
Unknown
Modality
small_molecule
Status
active

Clinical trials